Michael Quigley

Person

Ambler, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies binding to vista at acidic pH
- Patent number 12,091,462
- Issue date Sep 17, 2024
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunostimulatory agonistic antibodies for use in treating cancer
- Patent number 11,603,410
- Issue date Mar 14, 2023
- Bristol-Myers Squibb Company
- Marie-Claude Gaudreau
- G01 - MEASURING TESTING
Information Patent Grant
Co-therapy comprising a small molecule CSF-1R inhibitor and an agon...
- Patent number 10,857,230
- Issue date Dec 8, 2020
- Janssen Biotech, Inc.
- Michael Quigley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against OX40 and uses thereof
- Patent number 10,683,357
- Issue date Jun 16, 2020
- Bristol-Myers Squibb Company
- Zhehong Cai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonistic antibodies specifically binding CD40 and methods of use
- Patent number 10,544,229
- Issue date Jan 28, 2020
- Janssen Biotech, Inc.
- Johan Fransson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against OX40 and uses thereof
- Patent number 9,644,032
- Issue date May 9, 2017
- Bristol-Myers Squibb Company
- Zhehong Cai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
IMMUNOSTIMULATORY AGONISTIC ANTIBODIES FOR USE IN TREATING CANCER
- Publication number 20230357423
- Publication date Nov 9, 2023
- Bristol-Myers Squibb Company
- Marie-Claude GAUDREAU
- G01 - MEASURING TESTING
Information Patent Application
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS
- Publication number 20230287064
- Publication date Sep 14, 2023
- Bristol-Myers Squibb Company
- John J. ENGELHARDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Binding to Vista at Acidic pH
- Publication number 20220073617
- Publication date Mar 10, 2022
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-MERTK ANTIBODIES FOR TREATING CANCER
- Publication number 20210395392
- Publication date Dec 23, 2021
- Bristol-Myers Squibb Company
- Thomas E. Spires
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OX-40 AGONIST, PD-1 PATHWAY INHIBITOR AND CTLA-4 INHIBITOR COMBINAT...
- Publication number 20210277135
- Publication date Sep 9, 2021
- Bristol-Myers Squibb Company
- Chan GAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Co-Therapy Comprising A Small Molecule CSF-1R Inhibitor And An Agon...
- Publication number 20210093719
- Publication date Apr 1, 2021
- JANSSEN BIOTECH, INC.
- Michael QUIGLEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF A TETANUS TOXOID, ANTI-OX40 ANTIBODY AND/OR ANTI-PD-...
- Publication number 20200405806
- Publication date Dec 31, 2020
- Bristol-Myers Squibb Company
- Michael QUIGLEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST OX-40 AND USES THEREOF
- Publication number 20200399385
- Publication date Dec 24, 2020
- Bristol-Myers Squibb Company
- Zhehong CAI
- G01 - MEASURING TESTING
Information Patent Application
IMMUNOSTIMULATORY AGONISTIC ANTIBODIES FOR USE IN TREATING CANCER
- Publication number 20200369777
- Publication date Nov 26, 2020
- Bristol-Myers Squibb Company
- Marie-Claude GAUDREAU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS
- Publication number 20200207816
- Publication date Jul 2, 2020
- Bristol-Myers Squibb Company
- John J. ENGELHARDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS
- Publication number 20180312553
- Publication date Nov 1, 2018
- Bristol-Myers Squibb Company
- John J. ENGELHARDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CO-THERAPY COMPRISING A SMALL MOLECULE CSF-1R INHIBITOR AND AN AGON...
- Publication number 20180250398
- Publication date Sep 6, 2018
- JANSSEN BIOTECH, INC.
- Michael QUIGLEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST OX40 AND USES THEREOF
- Publication number 20180237534
- Publication date Aug 23, 2018
- Bristol-Myers Squibb Company
- Zhehong CAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST OX40 AND USES THEREOF
- Publication number 20170306035
- Publication date Oct 26, 2017
- Bristol-Myers Squibb Company
- Zhehong CAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Agonistic Antibodies Specifically Binding CD40 and Methods of Use
- Publication number 20170088624
- Publication date Mar 30, 2017
- JANSSEN BIOTECH, INC.
- Johan Fransson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST OX40 AND USES THEREOF
- Publication number 20160347849
- Publication date Dec 1, 2016
- Bristol-Myers Squibb Company
- Zhehong CAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS
- Publication number 20150322119
- Publication date Nov 12, 2015
- Bristol-Myers Squibb Company
- John J. ENGELHARDT
- C07 - ORGANIC CHEMISTRY

Michael Quigley

Person

Patents Grantslast 30 patents

Antibodies binding to vista at acidic pH

Immunostimulatory agonistic antibodies for use in treating cancer

Co-therapy comprising a small molecule CSF-1R inhibitor and an agon...

Antibodies against OX40 and uses thereof

Agonistic antibodies specifically binding CD40 and methods of use

Antibodies against OX40 and uses thereof

Patents Applicationslast 30 patents

IMMUNOSTIMULATORY AGONISTIC ANTIBODIES FOR USE IN TREATING CANCER

ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS

Antibodies Binding to Vista at Acidic pH

ANTI-MERTK ANTIBODIES FOR TREATING CANCER

OX-40 AGONIST, PD-1 PATHWAY INHIBITOR AND CTLA-4 INHIBITOR COMBINAT...

Co-Therapy Comprising A Small Molecule CSF-1R Inhibitor And An Agon...

COMBINATION OF A TETANUS TOXOID, ANTI-OX40 ANTIBODY AND/OR ANTI-PD-...

ANTIBODIES AGAINST OX-40 AND USES THEREOF

IMMUNOSTIMULATORY AGONISTIC ANTIBODIES FOR USE IN TREATING CANCER

ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS

ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS

CO-THERAPY COMPRISING A SMALL MOLECULE CSF-1R INHIBITOR AND AN AGON...

ANTIBODIES AGAINST OX40 AND USES THEREOF

ANTIBODIES AGAINST OX40 AND USES THEREOF

Agonistic Antibodies Specifically Binding CD40 and Methods of Use

ANTIBODIES AGAINST OX40 AND USES THEREOF

ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS